New cancer drug enters first human safety tests
NCT ID NCT05840224
Summary
This is an early-stage study to find out if a new drug called GS-4528 is safe for people with advanced solid tumors. Researchers are testing it by itself and combined with an existing immunotherapy drug. The main goals are to check for side effects and determine the best dose for future testing.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Asan Medical Center
Seoul, 05505, South Korea
-
Chang Gung Memorial Hospital Linkuo Branch of the Chang Gung Medical Foundation
Taoyuan District, 333, Taiwan
-
Clinica Universidad de Navarra- Unidad Central de Ensayos Clinicos
Pamplona, 31008, Spain
-
Hospital Universitari Vall D'Hebron- Oncology Service
Barcelona, 08035, Spain
-
NEXT Oncology-Hospital Quironsalud Barcelona - Unidad de Ensayos Fase 1
Barcelona, 08023, Spain
-
National Taiwan University Hospital
Taipei, 100229, Taiwan
-
START MADRID_HM Sanchinarro-CIOCC-Unidad de Ensayos Fases I
Madrid, 28050, Spain
-
START MADRID_Hospital Universitario Fundacion Jimenez Diaz - Unidad de Ensayos Fases I
Madrid, 28040, Spain
-
Samsung Medical Center
Seoul, 06351, South Korea
-
Severance Hospital, Yonsei University Health Systems
Seoul, 06273, South Korea
-
St Bartholomew's Hospital
London, E1 1FR, United Kingdom
-
Taichung Veterans General Hospital
Taichung, 40705, Taiwan
-
The Ottawa Hospital
Ottawa, K1H 8L6, Canada
-
The Royal Marsden NHS Foundation Trust
Sutton, SM2 5PT, United Kingdom
-
The University of Washington/FHCC
Seattle, Washington, 98109, United States
-
University Health Network, Princess Margaret Cancer Centre
Toronto, M5G 1Z5, Canada
Conditions
Explore the condition pages connected to this study.